This federal contract award, valued at $3,334.55, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of 4566752002, a 36mg extended-release formulation of the medication Concerta, with a period of performance through December 16, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order against the IDC contract covers a critical medication used in the treatment of conditions such as attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for the provision of similar medical products and prescription drugs.
Generated 3/14/25, 10:03 AM